Teuku Heriansyah

551 total citations
59 papers, 392 citations indexed

About

Teuku Heriansyah is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Teuku Heriansyah has authored 59 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 11 papers in Molecular Biology. Recurrent topics in Teuku Heriansyah's work include Lipoproteins and Cardiovascular Health (10 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers) and Cancer, Lipids, and Metabolism (9 papers). Teuku Heriansyah is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers) and Cancer, Lipids, and Metabolism (9 papers). Teuku Heriansyah collaborates with scholars based in Indonesia, United States and India. Teuku Heriansyah's co-authors include Mohammad Saifur Rohman, Jonny Karunia Fajar, Titin Andri Wihastuti, Djanggan Sargowo, Anwar Santoso, Meddy Setiawan, Bagus Aulia Mahdi, Sri Andarini, Nashi Widodo and Bambang Budi Siswanto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hypertension and Vascular Health and Risk Management.

In The Last Decade

Teuku Heriansyah

55 papers receiving 381 citations

Peers

Teuku Heriansyah
Dae‐Hee Shin South Korea
Teuku Heriansyah
Citations per year, relative to Teuku Heriansyah Teuku Heriansyah (= 1×) peers Dae‐Hee Shin

Countries citing papers authored by Teuku Heriansyah

Since Specialization
Citations

This map shows the geographic impact of Teuku Heriansyah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teuku Heriansyah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teuku Heriansyah more than expected).

Fields of papers citing papers by Teuku Heriansyah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teuku Heriansyah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teuku Heriansyah. The network helps show where Teuku Heriansyah may publish in the future.

Co-authorship network of co-authors of Teuku Heriansyah

This figure shows the co-authorship network connecting the top 25 collaborators of Teuku Heriansyah. A scholar is included among the top collaborators of Teuku Heriansyah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teuku Heriansyah. Teuku Heriansyah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Sujuti, Hidayat, et al.. (2024). Nicotine is associated with smoking dependence and vascularinflammation through cotinine: A mediation analysis. Tobacco Induced Diseases. 22(January). 1–9. 1 indexed citations
10.
11.
Heriansyah, Teuku, et al.. (2019). Lp-PLA2 Selective Inhibitor (Darapladib) Effect In Lowering The Expression Level Of IL-1B And IL-6 In The Renal At Type 2 Diabetes Mellitus. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Heriansyah, Teuku, et al.. (2019). Polysaccharide peptide (PsP) Ganoderma lucidum: a potential inducer for vascular repair in type 2 diabetes mellitus model. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Setiawan, Meddy, et al.. (2019). Decreasing angiogenesis vasa vasorum through Lp-PLA 2 and H 2 O 2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2. Journal of Basic and Clinical Physiology and Pharmacology. 30(6). 11 indexed citations
14.
Heriansyah, Teuku, et al.. (2019). <p>Lp-PLA<sub>2</sub> Selective Inhibitor (Darapladib) Effect In Lowering The Expression Level Of IL-1B And IL-6 In The Renal At Type 2 Diabetes Mellitus</p>. Vascular Health and Risk Management. Volume 15. 503–508. 5 indexed citations
16.
Wihastuti, Titin Andri & Teuku Heriansyah. (2017). The Inhibitory Effects of Polysaccharide Peptides (PsP) of Ganoderma lucidum against Atherosclerosis in Rats with Dyslipidemia. Heart International. 12(1). heartint.500023–heartint.500023. 15 indexed citations
17.
Wihastuti, Titin Andri, et al.. (2015). Effects of subchronic exposure of PSP Ganoderma lucidum on renal function and histopathology feature in Rattus novergicus Wistar strain. National Journal of Physiology Pharmacy and Pharmacology. 5(4). 296–296. 4 indexed citations
18.
Heriansyah, Teuku, et al.. (2015). Atherogenesis inhibition by darapladib administration in dyslipidemia model Sprague-Dawley rats. National Journal of Physiology Pharmacy and Pharmacology. 6(1). 52–52. 6 indexed citations
19.
Heriansyah, Teuku. (2014). HUBUNGAN INDEKS MASSA TUBUH DENGAN JUMLAH CIRCULATING ENDOTHELIAL CELL. SHILAP Revista de lepidopterología. 14(1). 1–6. 1 indexed citations
20.
Heriansyah, Teuku. (2013). PENGARUH BERBAGAI DURASI PEMBERIAN DIET TINGGI LEMAK TERHADAP PROFIL LIPID TIKUS PUTIH (Rattus Novergicus Strain Wistar) JANTAN. Jurnal Kedokteran Syiah Kuala. 13(3). 144–150. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026